Back to News
Feb 24, 2026 8:01 AM

Kiniksa Pharmaceuticals Q4 Earnings Assessment

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q4 earnings results on Tuesday, February 24, 2026 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Kiniksa Pharmaceuticals missed estimated earnings by -51.43%, reporting an EPS of $0.17 versus an estimate of $0.35.

Revenue was up $79.59 million from the same period last year.

Previous Earnings Records

The company missed on EPS ...